Correction to: Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma

Affiliations

Sekwon Jang: Melanoma and Cutaneous Oncology Therapeutics, Inova Schar Cancer Institute
Tayla Poretta: Health Economics and Outcomes Research, Bristol Myers Squibb
Tarun Bhagnani: Health Economics and Outcomes Research, EPI-Q Inc.
Qing Harshaw: Health Economics and Outcomes Research, EPI-Q Inc.
Matthew Burke: Health Economics and Outcomes Research, Bristol Myers Squibb
Sumati Rao: Health Economics and Outcomes Research, Bristol Myers Squibb

Abstract

The presentation of the numbers of patients in Tables 1 and 3 was adjusted